PATHOQUEST
DEAD

Serial Number

79195950

Owner

PATHOQUEST

Attorney

Anna L. King

Filing Date

Jul 13, 2016

Add to watchlist:

No watchlists yet
View on USPTO

PATHOQUEST Trademark

Serial Number: 79195950

PATHOQUEST is a trademark filed by PATHOQUEST on July 13, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

PATHOQUEST (2 trademarks)

BIOPARK BATIMENT B, 11 RUE WATT
PARIS F-75013 , FR

Entity Type: 99

Trademark Details

Filing Date

July 13, 2016

Registration Date

Not Registered

Published for Opposition

September 26, 2017

Goods & Services

Computers; computer systems, namely, software for compiling scientific and biological data and electronic databases recorded on computer media in the field of laboratory analysis and diagnostics; computer systems, namely, software for analyzing scientific and biological data and electronic databases recorded on computer media for scientific and biological use; computer systems comprised of computer hardware and peripherals and software for collecting, storing, analysis and reporting of biological information, and follow-up projects and monitoring of samples, workflows and laboratory data; chemical and biological analysis software; software for collecting, storing, analyzing, monitoring, and reporting and electronic databases recorded on computer media, all of the foregoing dedicated to the fields of diagnostics and metagenomics; software for detecting and analyzing of pathogens in a biological sample and electronic databases referencing publicly available collections of genomic information on bacteria and viruses recorded on computer media; laboratory apparatus and instruments for the detection of pathogens in a biological sample

Medical diagnostic services, namely, testing and analysis in the field of disease diagnosis; collection and analyses of human blood for medical purposes; preparing and processing biological samples for medical and pharmaceutical use intended for analysis in laboratories, namely, disease diagnostics; medical analysis in the nature of medical testing for diagnosis; medical analysis in the nature of medical testing of biological molecules, genomes and metagenomes for diagnosing of pathogens and infectious diseases; medical and health services relating to DNA, genetics and genetic testing, namely, genetic counseling and genetic testing for medical purposes; DNA analysis services for medical purposes; preparation and compilation of medical reports; medical testing services relating to disease diagnosis and treatment; medical analysis services for the diagnosis and treatment of persons; carrying out disease diagnoses; medical testing for the diagnosis and treatment of persons

Scientific testing services, namely, for testing and analysis in the field of DNA analysis; medical testing services in the field of pharmaceutical testing; microbiological testing services, namely, providing microbiological sample testing for others in the fields of medicine and research related thereto; computer-aided testing services, namely, genetic testing for research purposes; collection and analysis of blood for scientific purposes; preparation of biological samples to be analyzed in a laboratory; conducting analysis and products testing in the biological, pharmaceutical and bio-pharmaceutical fields; analysis and evaluation of the toxicity and safety of biological and pharmaceutical products, and their components; conducting analyses and tests by metagenomics; arranging and conducting of scientific and technical reports; advisory services relating to laboratory tests; scientific and medical laboratory services; services of laboratory for the preparation, detection, quantification and analysis of biological materials, for genotyping, for diagnostic tests and for the sequencing of biological molecules, genomes and metagenomes; laboratory services for DNA analysis; biological, bacteriological, medical and pharmacological research services; design, development and updating of software and databases dedicated to the fields of diagnostics and metagenomics; research and development in the field of genome research and genetic expression; biotechnology research and development

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 27, 2021 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jan 3, 2021 RHRD
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 20, 2020 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 5, 2020 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2020 FICR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 29, 2019 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Sep 19, 2019 RHRD
ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Mar 5, 2019 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Mar 5, 2019 ABN4
OPPOSITION TERMINATED NO. 999999
Mar 5, 2019 OP.T
OPPOSITION SUSTAINED NO. 999999
Mar 5, 2019 OP.S
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2019 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 27, 2018 OPNX
REFUSAL PROCESSED BY IB
Apr 20, 2018 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 11, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 11, 2018 OPNR
OPPOSITION INSTITUTED NO. 999999
Mar 27, 2018 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 26, 2018 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Mar 24, 2018 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 18, 2017 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 11, 2017 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 11, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 11, 2017 GNSL
SUSPENSION LETTER WRITTEN
Apr 11, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2017 TROA
REFUSAL PROCESSED BY IB
Dec 17, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 28, 2016 RFCS
REFUSAL PROCESSED BY MPU
Nov 28, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 24, 2016 RFCR
NON-FINAL ACTION WRITTEN
Nov 23, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 22, 2016 MAFR
ASSIGNED TO EXAMINER
Nov 16, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 10, 2016 REPR